Showing results (311-320 of 321) with videos related to
Sort By:
Pageof 33
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 16, 2026
Recipient interleukin-1β production is critical for lung allograft acceptanceAmit I Bery, Yuhei Yokoyama, Venkatrao Nunna, et al.Cell Reports|April 24, 2026
Inflammaging in aged tissues drives remodeling of the CD8+ T cell compartmentIrina Shchukina, Carlos J Rodriguez-Hernandez, Heather S Ruiz, et al.Immunity|July 28, 2021
Resident cardiac macrophages mediate adaptive myocardial remodelingNicole R Wong, Jay Mohan, Benjamin J Kopecky, et al.Nature Communications|July 21, 2021
Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injuryWulf Tonnus, Claudia Meyer, Christian Steinebach, et al.American Journal of Respiratory and Critical Care Medicine|July 17, 2020
Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical TrialSteven L Brody, Sean P Gunsten, Hannah P Luehmann, et al.Science Translational Medicine|February 25, 2026
Lymphatic disruption drives lung transplant fibrosis through interleukin-1-mediated hyaluronan accumulationHailey M Shepherd, Wenjun Li, Benjamin J Kopecky, et al.Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.Nature|October 24, 2024
Targeting immune-fibroblast cell communication in heart failureJunedh M Amrute, Xin Luo, Vinay Penna, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 7, 2026
Myeloid-avid mTOR-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantationKatsutaka Mineura, Charles R Liu, Junedh M Amrute, et al.Science (New York, N.Y.)|January 29, 2026
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapyJunedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, et al.Pageof 33